HIPPOCRATES Prospective Observational Study
HIPPOCRATES is an Innovative Medicines Initiative (IMI) funded EU Consortium established to address key unmet clinical needs in psoriatic disease. As part of the project, the HIPPOCRATES Prospective Observational Study (HPOS) is a study of patients with psoriasis which will run across Europe. The study will be led by a
| Condition(s) | Psoriatic Arthritis, Psoriasis |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | HIPPOCRATES is an Innovative Medicines Initiative (IMI) funded EU Consortium established to address key unmet clinical needs in psoriatic disease. As part of the project, the HIPPOCRATES Prospective Observational Study (HPOS) is a study of patients with psoriasis which will run across Europe. The study will be led by a research team at University of Oxford and supported by a team at University College Dublin. We are aiming to identify people with psoriasis who are at risk of developing psoriatic arthritis. Up to one-third of patients with psoriasis will develop a related arthritis causing inflammation in the joints and tendons. We want to identify which patients will develop arthritis with the long-term and ambitious aim of trying to prevent the development of arthritis before it occurs. W |
| Who can participate | Inclusion Criteria: * Adult ≥18 years * Self-reported diagnosis of skin psoriasis (any form) * Participant is willing and able to give informed consent for participation in the study and complete data in one of the HPOS languages Exclusion Criteria: • Pre-existing diagnosis of PsA |
| Ages | 18 Years |
| Sex | All |
| Lead sponsor | University of Oxford |
| Locations | Oxford, Oxfordshire, United Kingdom |
| Start date | 2023-06-27 |
| NCT ID | NCT05858528 |
| Official listing | https://clinicaltrials.gov/study/NCT05858528 |